References
- Crissey J. T. Common dermatophyte infections: a simple diagnostic test and current management. Postgrad Med 1998; 103: 191–2
- Pierard G. E., Arrese J. E., Pierard‐Franchimont C. Treatment and prophylaxis of tinea infections. Drugs 1996; 52: 209–24
- Elewski B. E. Mechanisms of action of systemic antifungal agents. J Am Acad Dermatol 1993; 28: S28–S34
- McNeely W., Spencer C. M. Butenafine. Drugs 1998; 55: 405–12
- Lesher J. L Jr., Babel D. E., Stewart D. M., Jones T. M., Kaminester L., Goldman M., et al. Butenafine 1% cream in the treatment of tinea cruris: a multicenter, vehicle‐controlled, double‐blind trial. J Am Acad Deramatol 1997; 36: S20–S24
- Arika J., Hase J., Yokoo M. Antitrichophyton mentagrophytes activity and percutaneous permeation of butenafine in guinea pigs. Antimicrob Agents Chemother 1993; 37: 363–5
- Arika T., Yokoo M., Hase T., Maeda T., Amemiya K., Yamaguchi H. Effects of butenafine hydrochloride, a new benzylamine derivative, on experimental dermatophytosis in guinea pigs. Antimicrob Agents Chemother 1990; 34: 2250–3
- Savin R., De Villez R. L., Elewski B., Hong S., Jones T., Lucky A., et al. One‐week therapy with twice‐daily butenafine 1% cream versus vehicle in the treatment of tinea pedis: a multicenter, double‐blind trial. J Am Acad Dermatol 1997; 36: S15–S19
- Greer D. L., Weiss J., Rodriguez D. A., Hebert A. A., Swinehart J. M. A randomized trial to assess once‐daily topical treatment of tinea corporis with butenafine, a new antifungal agent. J Am Acad Dermatol 1997; 37: 231–5
- Berman B., Ellis C., Leyden J., Lowe N., Savin R., Shupack J. Efficacy of a 1‐week twice‐daily regimen of terbinafine 1% cream in the treatment of interdigital tinea pedis. J Am Acad Dermatol 1992; 26: 956–60